Back
Akero Therapeutics, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
55
AKRO
Akero Therapeutics, Inc.
Last Price:
$54.65
Seasonality Move:
1.27%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAkero Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Akero Therapeutics, Inc. has on average historically risen by 34.5% based on the past 6 years of stock performance.
-
Akero Therapeutics, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Akero Therapeutics, Inc. Stock Undervalued?The current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Akero Therapeutics, Inc. has on average historically risen by 34.5% based on the past 6 years of stock performance.
Akero Therapeutics, Inc. Stock Rating
Buy
55
Akero Therapeutics, Inc. (AKRO)
is a Buy
Is Akero Therapeutics, Inc. overpriced?
-
Akero Therapeutics, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Akero Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com/
52-Week Data
52-Week High:
58.40
52-Week Low:
21.34
Prediction Charts
Market Cap:
4.5B
Price in USD:
54.65
Volume:
0
Beta:
-0.03
Technical Analysis
SMA50:
54.21
SMA100:
50.58
SMA200:
48.49
52-Wk Change:
90.35%
Stock Predictions
-
Is Akero Therapeutics, Inc. stock public?Yes, Akero Therapeutics, Inc. is a publicly traded company.
-
What is the Akero Therapeutics, Inc. stock quote today?The Akero Therapeutics, Inc. stock price is 54.65 USD today.
-
How to buy Akero Therapeutics, Inc. stock online?You can buy Akero Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-1 | 54.35 | 54.44 | 54.48 | 54.35 |
| Dec-2 | 54.46 | 54.49 | 54.52 | 54.42 |
| Dec-3 | 54.49 | 54.69 | 54.70 | 54.44 |
| Dec-4 | 54.68 | 54.63 | 54.69 | 54.53 |
| Dec-5 | 54.65 | 54.55 | 54.65 | 54.30 |
| Dec-8 | 54.52 | 54.65 | 54.83 | 54.37 |
| Dec-9 | 54.65 | 54.65 | 54.65 | 54.65 |
| Dec-10 | 54.65 | 54.65 | 54.65 | 54.65 |
| Dec-11 | 54.65 | 54.65 | 54.65 | 54.65 |
| Dec-12 | 54.65 | 54.65 | 54.65 | 54.65 |
| Dec-15 | 54.65 | 54.65 | 54.65 | 54.65 |
| Dec-16 | 54.65 | 54.65 | 54.65 | 54.65 |
| Dec-17 | 54.65 | 54.65 | 54.65 | 54.65 |
| Dec-18 | 54.65 | 54.65 | 54.65 | 54.65 |
Akero Therapeutics, Inc. Earnings
Akero Therapeutics, Inc. Earnings Report: Per Share Akero Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics, Inc. Forecast Revenue Growth
Akero Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.32 per share.
* Akero Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.